What’s really happening in the peptide, hormone, and longevity space—and what’s simply hype? In this episode of Under Contract, we welcome back Dr. Gabriel Alizaidy for an honest conversation about peptides, GLP-1 medications, hormone replacement therapy, testosterone, mitochondrial health, and the future of longevity medicine. We discuss the recent FDA and pharmaceutical industry developments affecting peptide access, whether peptides are becoming the “new supplements,” and why medical supervision and blood work are essential. Dr. Alizaidy also explains why certain mitochondrial peptides may be overhyped, how MOTS-c and SS-31 differ, how to safely optimize hormones, and why testosterone is often overlooked for both men and women. The conversation also explores: • GLP-1 medications, weight loss, appetite, and muscle preservation • HRT, testosterone, estrogen, and progesterone • The risks of taking too many supplements or peptides • Sleep, exercise, nutrition, and stress resilience • Longevity treatments that could backfire • Why grip strength may be an underrated health metric • The future of topical, oral, and intranasal peptide therapies This episode is for educational and informational purposes only and is not medical advice. Always consult a qualified healthcare professional before beginning peptides, hormone therapy, GLP-1 medications, or any new health protocol. #Peptides #GLP1 #HormoneReplacementTherapy #Testosterone #Longevity #Biohacking #HealthOptimization #MitochondrialHealth #WeightLoss #hrtc Website: alizaidy.com Instagram: @gabrielalizaidy 00:00 Peptides, Hormones & the Future of Longevity Medicine 01:15 FDA Regulations, Eli Lilly Lawsuits & Peptide Access 06:36 Overhyped Peptides: MOTS-c vs. SS-31 Explained 11:19 Stress, Aging & the Risks of Over-Optimization 17:22 Testosterone, HRT & Hormone Myths for Men and Women 24:10 GLP-1 Medications, Weight Loss & Next-Generation Peptides 32:52 The Health Basics That Matter: Sleep, Diet, Exercise & Safety